CSL Limited (OTCMKTS:CSLLY) Short Interest Up 151.1% in December

CSL Limited (OTCMKTS:CSLLY - Get Free Report) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 11,800 shares, an increase of 151.1% from the December 15th total of 4,700 shares. Based on an average daily volume of 159,800 shares, the short-interest ratio is currently 0.1 days.

CSL Price Performance

OTCMKTS:CSLLY traded up $0.48 during trading hours on Tuesday, hitting $86.87. The company's stock had a trading volume of 116,195 shares, compared to its average volume of 67,587. CSL has a 52-week low of $83.31 and a 52-week high of $109.00. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.97 and a current ratio of 2.18. The stock has a fifty day moving average of $89.69 and a 200-day moving average of $96.77.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.